Exploring Novel Aptamer-Heparin Combinations to Improve Anticoagulation Therapy in Cardiopulmonary Bypass

被引：0
|
作者：
Chabata, Charlene V. [1 ]
Gunaratne, Ruwan [1 ]
Frederiksen, James W. [1 ]
Sullenger, Bruce A. [1 ]
机构：
[1] Duke Univ, Pharmacol, Durham, NC USA
来源：
MOLECULAR THERAPY | 2019年 / 27卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
784
引用
收藏
页码：364 / 365
页数：2
相关论文
共 50 条
  • [31] Recombinant hirudin for cardiopulmonary bypass anticoagulation: A randomized, prospective, and heparin-controlled pilot study
    Riess, F.-C.
    Poetzsch, B.
    Madlener, K.
    Cramer, E.
    Doll, K.-N.
    Doll, S.
    Lorke, D. E.
    Kormann, J.
    Mueller-Berghaus, G.
    THORACIC AND CARDIOVASCULAR SURGEON, 2007, 55 (04): : 233 - 238
  • [32] Heparinized cardiopulmonary bypass and full heparin dose marginally improve clinical performance
    Ovrum, E
    Holen, EA
    Tangen, G
    Ringdal, MAL
    ANNALS OF THORACIC SURGERY, 1996, 62 (04): : 1128 - 1133
  • [33] Evaluation of a point of care anticoagulation assay: The heparin management test (HMT) during cardiopulmonary bypass
    Wallock, M
    Jeske, WP
    Wood, JJ
    Bakhos, M
    Walenga, JM
    THROMBOSIS AND HAEMOSTASIS, 1999, : 87 - 87
  • [34] Anticoagulation Management and Heparin Resistance During Cardiopulmonary Bypass: A Survey of Society of Cardiovascular Anesthesiologists Members
    Sniecinski, Roman M.
    Bennett-Guerrero, Elliott
    Shore-Lesserson, Linda
    ANESTHESIA AND ANALGESIA, 2019, 129 (02): : E41 - E44
  • [35] Effect of combined anticoagulation using heparin and bivalirudin on the hemostatic and inflammatory responses to cardiopulmonary bypass in the rat
    Welsby, Ian J.
    Jones, Wilbert L.
    Arepally, Gowthami
    De lange, Fellery
    Yoshitani, Kenji
    Phillips-Bute, Barbara
    Grocott, Hilary P.
    Becker, Richard
    Mackensen, G. Burkhard
    ANESTHESIOLOGY, 2007, 106 (02) : 295 - 301
  • [36] Anticoagulation for patients with heparin-induced thrombocytopenia using recombinant hirudin during cardiopulmonary bypass
    Liu, H
    Fleming, NW
    Moore, PG
    JOURNAL OF CLINICAL ANESTHESIA, 2002, 14 (06) : 452 - 455
  • [37] Management of anticoagulation during cardiopulmonary bypass in a patient with allergy to heparin and heparin-like compounds: a case-report
    Balthazar, Severine
    Watremez, Christine
    Vigneault, Louise
    Eeckhoudt, Stephane
    Pirson, Francoise
    Hermans, Cedric
    BLOOD COAGULATION & FIBRINOLYSIS, 2014, 25 (08) : 900 - 903
  • [38] Combining Heparin and a FX/Xa Aptamer to Reduce Thrombin Generation in Cardiopulmonary Bypass and COVID-19
    Chabata, Charlene V.
    Frederiksen, James W.
    Olson, Lyra B.
    Naqvi, Ibtehaj A.
    Hall, Sharon E.
    Gunaratne, Ruwan
    Kraft, Bryan D.
    Que, Loretta G.
    Chen, Lingye
    Sullenger, Bruce A.
    NUCLEIC ACID THERAPEUTICS, 2022, 32 (03) : 139 - 150
  • [39] HEPARIN ANTICOAGULATION DURING CARDIOPULMONARY BYPASS IN AN ANTI-THROMBIN-III DEFICIENT PATIENT - IMPLICATIONS RELATIVE TO THE ETIOLOGY OF HEPARIN REBOUND
    SOLOWAY, HB
    CHRISTIANSEN, TW
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1980, 73 (05) : 723 - 725
  • [40] Evaluation of a point of care anticoagulation assay: The Heparin Management Test (HMT) during cardiopulmonary bypass.
    Wallock, M
    Jeske, W
    Walenga, J
    Iqbal, O
    Bakhos, M
    CLINICAL CHEMISTRY, 1998, 44 : A70 - A70
12345